key: cord-0745018-61qxjd9f authors: Singer, Pierre title: Nutritional and metabolic management of the COVID 19 intensive care patient. date: 2021-03-01 journal: nan DOI: 10.1016/j.jointm.2021.01.004 sha: 8e30c810835fe0242be4e042380772124467cd78 doc_id: 745018 cord_uid: 61qxjd9f Nutritional and metabolic disturbances are observed in critically ill COVID 19 patients. The aim of this review is to describe these disturbances during the progression of the disease, from the pre intubation through the ventilated condition to the post extubation phase. Analysis of new data describing the prevalence of malnutrition, the modifications in energy expenditure and body composition are guiding medical nutritional therapy to prevent from severe energy deficit and muscle loss. Rehabilitation may be very prolonged and therefore, nutrition is mandatory to decrease this recondition period. This review comments also on the ESPEN nutritional statements. nutritional status. These changes have strong metabolic and nutritional consequences on body composition and ability of the patients to overcome the disease or to efficiently recover from it. From statements mainly based on existing ESPEN guidelines (4), more recommendations have been published based on the recent accumulated experience (5, 6, 7, 8) . This document summarizes the up to date knowledge of the metabolic effects and the recommended nutritional therapy of critically ill Covid 19 patients. In a recent study among 523 patients with COVID-19 (9) , the 211 patients admitted to the intensive care unit (ICU) were older and mainly male, and had a lower BMI and HDL cholesterol as compared to patients treated outside of the ICU . Forty five percent died and they suffered more morbidities as described previously (10) . Patients with higher Nutritional Risk Score (NRS) (higher than 5 points) had a significantly increased risk of in -hospital death as compared to those with lower NRS scores (OR=1.880, CI 95% 1.151-3.070), suggesting that malnutrition may be an additional risk of mortality. Once admitted to the ICU, patients with respiratory distress not requiring invasive ventilation are generally treated with high flow nasal cannula oxygen therapy or non-invasive ventilation, are suffering respiratory distress and while breathing spontaneously, are treated with oxygen supplementation up to high flow nasal cannula oxygen therapy or non-invasive ventilation. As a result, oral intake decreases significantly and enteral/parenteral nutrition is prescribed -often times in a nonoptimal fashion but not optimally (11) . This decrease in energy/protein intake is associated with a prolonged immobilization that increases catabolism and muscle loss. In an audit recruiting 268 COVID 19 ICU patients, Pironi et al (12) found that 75% of the patients were at risk of malnutrition (using NRS), and, using the GLIM classification (13), 54% were diagnosed as suffering from severe malnutrition and 35% from moderate malnutrition from among the 151 evaluated patients. Rouget et al (14) also demonstrated also the existence of a high prevalence of malnutrition (37.5%) in a general cohort of COVID-19 inpatients according to GLIM criteria. In an additional study (15) , the muscle wasting was observed in all examined subjects. They suffered a fat mass loss equal to about 9%. This was attributable to an unusually prolonged increase in energy expenditure which was partially attributable to fever and inflammatory status. In the initial period of the acute phase, in response to the injury, an endogenous energy production occurs, between 500 and 1400 kcal/day, which is added to the daily energy expenditure. In the late period of the acute phase, resistance to anabolism occurs, with the consumption of energy and protein reserves. Regarding muscle mass, Virgensa et al (16) analyzed the severe inflammatory process secondary to a cytokine storm, observed mainly in elderly and obese COVID 19 patients, . Severe loss of muscle mass was observed. Immobilization is also a factor of lean mass loss. Recently, a longitudinal observational study described energy expenditure in 22 COVID 19 ventilated patients measured by indirect calorimetry (17) . Interestingly, measured energy expenditure increased progressively from week 1 (1568 kcal/d, range 1175-2215 kcal/d) to week 2 (1830 kcal/d, range 1465-2467 kcal/d) and week 3 (2789 kcal/d, range 1776-3262 kcal/d). In another study following 7 patients (18) , an extreme hypermetabolic state (mean 4044 Kcal/day with 235.7% ± 51.7% of predicted values) with extraordinary oxygen consumption and carbon dioxide production were observed. These new observations show that the acute phase may be more prolonged and that the post-acute phase may be associated with a strong hypermetabolism. Patients receiving more oxygen therapy had a significant decrease in oral intake. From 63 (23.5%) patients that received medical nutrition therapy, 16 received oral nutritional supplements, 34 enteral nutrition and 13 parenteral nutrition. The energy and protein targets were achieved according to the ESPEN guidelines for nutrition in the ICU (12) . There is a strong association between levels of circulating levels of 25-hydroxyvitamin D and COVID 19 positivity rates (19) suggesting that high levels may protect from contacting the virus. From the CovILD registry, (20) , these findings were confirmed. "A total of 109 patients were included in the analysis eight weeks after the onset of COVID-19, a high proportion of patients presented with impaired vitamin D metabolism and elevated parathyroid hormone (PTH) levels. PTH concentrations were increased in patients who needed intensive care unit (ICU) treatment, while vitamin D levels were not significantly different between disease severity groups. Low vitamin D levels at disease onset or at eightweek follow-up were not related to persistent symptom burden, lung function impairment, ongoing inflammation, or more severe CT abnormalities". The authors concluded that vitamin D deficiency is frequent among COVID-19 patients but not associated with disease outcomes. Selenium deficiency is associated with increased COVID 19 mortality (21) . Patients living in areas with poor baseline supply, as well as patients with pre-existing comorbidities such as lung diseases have an elevated risk for severe selenium deficiency and are more exposed to COVID 19 (21) . From the time the recent ESPEN guidelines on nutritional therapy were released (4), numerous studies have described the nutritional therapy according to the respiratory support allocated to the ICU patient (5-8) (see Figure 1 ). At the first wave, COVID-19 patients with early signs of respiratory distress were promptly treated with mechanical ventilation, based on the fear of disseminating the virus if non-invasive therapy was used. During the second wave, oxygen Flow Nasal Cannula (FNC), High Flow Nasal Cannula (HFNC) or non-invasive ventilation (NIV) using a mask or a helmet were prescribed for a longer period of time to avoid mechanical ventilation. The Statement Consideration number 7 (4) suggested that in COVID-19 non-intubated ICU patients not reaching the energy target with an oral diet, oral nutritional supplements (ONS) should be considered first and then enteral nutrition treatment. The introduction of a nasogastric or naso-duodenal tube should be performed with caution since many bleeding episodes have been reported, mainly if the patient was receiving full anticoagulation. Blind placement of duodenal tube has been proposed to decrease the need for gastroscopy or fluoroscopy (22) . If there are limitations for the enteral route it could be advised to prescribe peripheral/central parenteral nutrition in the population not reaching energy-protein target by oral or enteral nutrition. This approach has been confirmed by French and Chinese positions papers (5, 23) . The use of NIV may induce stomach dilatation and inadequate implementation of enteral feeding, resulting in partial undernutrition. In these cases, peripheral or central parenteral nutrition should be considered. The use of flow nasal cannula and HFNC may decrease oral alimentation. Few studies described the implementation of nutritional support when this technique is used. We recently described a significantly increase in the number of minor and massive gastro-eosphageal refluxes using HFNC, impairing calorie and protein intake (24) . Assessment of nutrient intake should be initiated. The exact timing to initiate mechanical ventilation is still unknown (25) . The ESPEN COVID statements recommend (4): Recommendation Statement Consideration 8: Enteral nutrition should be started through a nasogastric tube; post-pyloric feeding should be performed in patients with gastric intolerance after prokinetic treatment or in patients at high-risk for aspiration; the prone position per se does not represent a limitation or contraindication for EN. Patient energy expenditure (EE) should be determined to evaluate energy needs by using indirect calorimetry when available. The use of indirect calorimetry was discussed by scientific societies because of the fear of virus spread (6) . The practical guidance for safe use of indirect calorimetry has been recently proposed (26) allowing a larger use of indirect calorimetry in this specific population. As described above, Whittle et al (17) performed a longitudinal study of measured energy expenditure in 22 ventilated COVID 19 patients. Despite the cytokine storm, the first week was characterized by lower energy expenditure (15 to 20 kcal/kg actual body weight ABW in BMI < 30 and adjusted body weight in obese subjects after 1 week), hypermetabolism increased further and during the 3 rd week, reaching 150% of the predicted resting energy expenditure. Predictive equations such as the Harris Benedict equation were found to be inaccurate. A large variability in the measurements was also observed. If calorimetry is not available, VCO2 (carbon dioxide production) derived from the ventilator will give a better evaluation of EE than predictive equations (4). Energy administration should be guided by the recent ESPEN ICU Nutrition guidelines (27) and suggest that "hypocaloric nutrition (not exceeding 70% of EE) should be administered in the early phase of acute illness with increments of up to 80-100% after day 3. If predictive equations are used to estimate the energy need, hypocaloric nutrition (below 70% estimated needs) should be preferred over isocaloric nutrition for the first week of ICU stay due to reports of overestimation of energy needs". Interestingly, in a study including patients with COVID-19 (9), those who died were started later on nutritional support and received more parenteral nutrition (62.1% versus 10.3%, p<0.001). Protein requirements: The ESPEN statements recommend to deliver1.3 g/kg protein equivalents per day progressively. This statement is endorsed by Thibault et al (5) . The standing ASPEN recommendations for protein as 1.2-2 grams/kg of bodyweight is also relevant in this case (28) . COVID 19 patients are often bedridden for a prolonged period and suffer from hyperinflammation state. Both conditions lead to a loss of skeletal muscle mass and a hyperinflammatory condition. To enhance skeletal muscle anabolism, physical activity and mobilization are recommended. Recommendation Statement Consideration 9: "In ICU patients who do not tolerate full dose enteral nutrition during the first week in the ICU, initiating parenteral nutrition (PN) should be weighed on a case-by-case basis. PN should not be started until all strategies to maximize EN tolerance have been attempted". Patients suffering from uncontrolled life-threatening hypoxemia, hypercapnia or acidosis, and uncontrolled shock should not be fed enterally or parenterally until the shock is controlled with fluids and vasopressors or inotropes (27) . Progression to full nutrition should be performed cautiously in these patients. Re-feeding syndrome may occur, mainly if patients have been without adequate nutritional intake for a long period of time in fear of aspiration or respiratory decompensation requiring intubation. Finally blood glucose should be maintained at target levels between 6-8 mmol/l, along with monitoring of blood triglycerides and plasma levels of potassium, phosphate and magnesium. Prone position has become a frequent and valid technique to improve oxygenation (29) and nutritional therapy has been reviewed recently (30) . Most of the studies show that early administration of enteral nutrition, progressing to target is safe and well tolerated even at rates up to 85 mL/h at day 4. Prone position includes maintaining head of -bed elevation (reverse Trendelenburg) at 10-25° (31), and evaluating and managing risk factors on an individual basis. If enteral nutrition is not tolerated, parenteral nutrition should be considered. Large gastric residue is not more frequent in prone or supine position (31) . After prolonged intubation, swallowing problems and dysphagia occur and limit oral nutrient intake. Two hundred and eight patients were assessed for dysphagia, (102 post ICU patients of which 82 were tracheostomized) (32) . The time from extubation to oral intake was 5.3 +/-2.3 days and from tracheostomy to oral intake 14.8 +/-6.6 days. The majority of patients regained near normal swallow function prior to discharge, regardless of intubation duration or tracheostomy status after intensive speech therapy. A whole systems approach to managing dysphagia associated with Covid-19, including medical, surgical, nursing, therapy and education teams is therefore recommended. Recommendation Consideration Statement 10: "In ICU patients with dysphagia, texture-adapted food can be considered after extubation. If swallowing is proven unsafe, EN should be administered. In cases with a very high aspiration risk, postpyloric EN or, if not possible, temporary PN during swallowing training with removed nasoenteral tube can be performed". According to Curci et al (33) , 32 post-acute COVID-19 patients (22 male and 10 female), mean aged 72.6±10.9 years had a Barthel index of 45.2±27.6. All were dyspneic and only 14 were able to walk (43.7%). The 6 minutes walk trial (6-MWT) was feasible in 6 (18.8%) patients with a mean distance of 45.0±100.6 meters. In a single center study (34) from 143 patients recovering from COVID-19, 44% reported decreased quality of life and 87% of the patients reported persistent symptoms including dyspnea, chest pain, cough, fatigue and joint pain. The post COVID 19 chronic illness has many common features with the Persistent Inflammatory and Catabolic State (PICS) (35) . Loss of skeletal muscle mass and muscle function may be tremendous and a major problem, mainly in older adults and comorbid patients that are more prone to present with pre-existing catabolic conditions and impaired skeletal muscle mass and function. Bangash et al (36) suggested that the use of β-adrenergic blockers as antiarrhythmics with proven benefit in the cardiovascular arena, also has the potential ability to reduce systemic metabolic rate and catabolism, and modulate immune dysfunction (37) . Finally the authors propose nutritional supplements, such as niacin and folic acid, to intervene on muscle and the cardiovascular system, mediated through effects on DNA methylation and cellular energetics (38) . At each step of the progression of the disease, ICU COVID 19 patients should be carefully evaluated in terms of malnutrition risk and medical nutritional support. The tremendous challenge made by the continuous clinical changes requires adequate answers at each stage. A delay will induce more energy and protein deficit, and longer length of stay and rehabilitation for the survivors. Metabolic control and nutritional support are a cornerstone in the management of the COVID 19 critical ill patient. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections Gastrointestinal Manifestations of OVID-19: Impact on Nutrition Practices ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care. ASPEN and SCCM National Health Commission of the People's Republic of China /specials/diagnosisandtreatment-Africa Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City ENERGY AND PROTEIN INTAKE IN CRITICALLY ILL PATIENTS WITH RESPIRATORY FAILURE TREATED BY HIGH FLOW NASAL CANNULA (HFNC) OXYGENATION: An Observational Study.. Nutrition 2020 Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease GLIM criteria for the diagnosis of malnutrition -A consensus report from the global clinical nutrition community. GLIM Core Leadership Committee; GLIM Working Group Prevalence of malnutrition in COVID-19 inpatients: the Nutricov study Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations Wischmeyer PE ffor the LEEP-COVID Study Group: Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19 Hypermetabolism and COVID-19 HolickI D: SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry Seibert Let al: 1, Selenium Deficiency Is Associated with Mortality Risk from COVID-19 Practice of novel method of bedside postpyloric tube placement in patients with coronavirus disease 2019 Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan Reflux events detected by multichannel bioimpedance smart feeding tube during high flow nasal cannula oxygen therapy and enteral feeding: First case report Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. Front Med (Lausanne) Practical guidance for the use of indirect calorimetry during COVID 19 pandemic ESPEN guideline on clinical nutrition in the intensive care unit Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study Nutrition Support During Prone Positioning: An Old Technique Reawakened by COVID-19 Before-after study of a standardized ICU protocol for early enteral feeding in patients turned in the prone position Dysphagia presentation and management following coronavirus diseaseA 2019: an acute care tertiary centre experience Early rehabilitation in postacute COVID-19 patients: data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol Persistent Symptoms 595 in Patients After Acute COVID-19 PICS Persistent Inflammation, Immunosuppression, and Catabolism: Evolution of Multiple Organ Dysfunction COVID-19 recovery: potential treatments for post-intensive care syndrome β2 adrenergic receptormediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells Niacin cures systemic NAD+deficiency and improves muscle performance in adult-onset mitochondrial myopathy Flow chart of medical nutritional support according to the progression of the disease. ONS: oral nutritional therapy. HFNC: high flow nasal cannula oxygen therapy. NIV: non invasive ventilation The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.